NCT06000553
Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas
Not Yet Recruiting · Not Applicable · Institut Paoli-Calmettes · registry updated 2023-08-21
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
This trial is a prospective, exploratory and descriptive study. The primary objective is to identify early diagnostic biomarkers in patients with TIPMP based on the analysis of Treg lymphocyte subpopulations and epigenetic signatures, and the secondary objective is to characterize the biological processes underlying the transformation of a pre-neoplastic lesion into established ADPC.
Inclusion
- Patient with intermediate-risk or high-risk TIPMP according to the European Study Group on Cystic Tumours of the Pancreas (3)
- Signed consent to participate
- Affiliation with a social security scheme, or beneficiary of such a scheme.
Exclusion
- Pregnant or breast-feeding woman
- Person in an emergency situation or unable to give consent.
- Adult subject to a legal protection measure (adult under guardianship, curatorship or safeguard of justice),
- Unable to undergo medical follow-up for geographical, social or psychological reasons.
- contraindication to MRI.